Neoplasms, Ovarian Terminated Phase 2 Trials for Pembrolizumab (DB09037)

Also known as: Neoplasms,Ovarian / Ovarian Neoplasms / Ovarian Neoplasm / Ovarian neoplasia / Ovarian tumor / Ovarian neoplasm NOS

IndicationStatusPhase
DBCOND0030336 (Neoplasms, Ovarian)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02499952Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell TumorsTreatment